Target intelligence / Profile preview

Iron homeostasis pathways (null)

Target
null
Molecular classification
Other (regulatory pathway), Includes components that are: Enzyme, Transporter, Receptor, Transcription factor, Peptide hormone
01

Overview

Iron homeostasis pathways comprise the coordinated regulation of iron uptake (e.g., transferrin receptor 1, DMT1), storage (ferritin), export (ferroportin), and systemic control (hepcidin, BMP/SMAD signaling), as well as cellular regulators (iron regulatory proteins IRP1/2, iron responsive elements)[1][2][5][6]. This network ensures adequate iron for hemoglobin, myoglobin, DNA synthesis, and mitochondrial respiration, while preventing iron overload and toxicity[1][6]. Key regulatory circuits include the **hepcidin–ferroportin axis** for systemic control and the **IRP/IRE system** for cellular regulation[2]. Disruption is implicated in anemia, hemochromatosis, infections, cancer, and neurodegeneration[1][2][4]. To obtain structured information, you must specify a particular molecular component (e.g., "Hepcidin," "Ferroportin," "Transferrin receptor 1") within the iron homeostasis pathways. "Iron homeostasis pathways" as a term describes a complex biological process, not a single druggable target.

Other names
Iron regulation pathwaysIron metabolism pathwaysIron regulatory network
02

Mechanism of action

Not applicable for the overall pathway. For components: Iron chelation (removal of excess iron); Modulation of hepcidin-ferroportin signaling (altering iron export); Blocking or enhancing iron uptake via transferrin or divalent metal transporter 1 (DMT1); Alteration of iron storage/ferritin metabolism

03

Biological functions

Iron absorptionIron transportIron storageIron exportRegulation of redox balanceControl of heme and non-heme iron use
04

Disease associations

AnemiaCancerNeurodegenerative diseaseCardiovascular diseaseInfectionHemochromatosisIron overload disordersIron deficiency disorders
05

Safety considerations

Iron overload (toxicity, organ failure, increased infection risk)Iron deficiency (anemia, impaired immunity, neurological effects)Reactive oxygen species production causing cellular damage
06

Interacting drugs

Iron chelators (deferoxamine, deferasirox—target iron ions)

3 more in the full profile.

07

Biomarkers

Serum ironFerritinTransferrin saturationHepcidinTotal iron-binding capacity (TIBC)Soluble transferrin receptor (sTfR)

Beyond the preview

Go deeper on Iron homeostasis pathways (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron homeostasis pathways (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call